Nonagen Bioscience Corp

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$56Kgeneral payments (2019-2025)
$500research payments (2019-2025)
11clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2022 $35K
2023 $21K
2024 $0.00

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Urology $55K
Anatomic Pathology & Clinical Pathology $1,531

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Grannum Sant Bridgewater, NJ Urology $14,500.00
Gary Steinberg Chicago, IL Urology $11,593.75
Sijo Parekattil Winter Garden, FL Urology $8,750.00
Neal Shore Myrtle Beach, SC Urology $5,687.50
Patrick Villicana Plantation, FL Urology $3,500.00
Yair Lotan Dallas, TX Urology $2,625.00
Sergei Tikhonenkov Honolulu, HI Urology $2,625.00
Ashish Kamat Houston, TX Urology $2,625.00
Piyush Agarwal Chicago, IL Urology $1,750.00
Owen Chan Aiea, HI Anatomic Pathology & Clinical Pathology $1,531.25

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.